can semaglutide cause neck pain Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Weight Loss safety information

In a phase 2 trial involving people with obesity, the 12 mg weekly dose of retatrutide resulted in a placebo-adjusted mean weight reduction of 22.1% after 48 weeks of treatment

PlexusDx supports ongoing therapy for patients who benefit from continued appetite suppression

Thyroid Cancer Risk There is a potential risk associated with thyroid cancer, particularly medullary thyroid carcinoma (MTC)

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials[J].The Lancet Diabetes & Endocrinology,2021,9(8):653-662

Ongoing studies, including TOGETHER-PsA and TOGETHER AMPLIFY-PsA, are expected to generate critical real-world data on tolerability, metabolicimmune interactions, and long-term safety of this combined therapeutic approach

It also causes gastrointestinal side effects in a steadier pattern rather than short bursts each day